Brief: Scilex Holding Company Announces Commercial Launch Of Elyxybtm In U.S.
27/02/2023 14:13
Feb 27 (Reuters) - Scilex Holding Co SCLX.O :
* SCILEX HOLDING COMPANY ANNOUNCES COMMERCIAL LAUNCH OF
ELYXYBTM
(CELECOXIB ORAL SOLUTION) IN U.S.
Source text for Eikon: ID:nGNX4qCMbt
Further company coverage: SCLX.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20